Trisomy of BACH1 inhibits antioxidant genes HO‐1, leading to inhibition of HO‐1/BVR‐A pathway and facilitating AD pathology progression in DS individualsBACH1 suppress MAPT expression, leading to the observed molecular gender differences in tauopathies and AD. This evidence concerns the gene MAPT and tauopathy.